PRODUCTION OF RECOMBINANT SERPINS IN ESCHERICHIA COLI

被引:3
作者
Pearce, Mary C. [1 ]
Cabrita, Lisa D. [2 ]
机构
[1] Monash Univ, Dept Biochem, Clayton, Vic 3168, Australia
[2] UCL, Dept Biol Mol & Struct, London, England
来源
METHODS IN ENZYMOLOGY, VOL 501: SERPIN STRUCTURE AND EVOLUTION | 2011年 / 501卷
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; EPITHELIUM-DERIVED FACTOR; CELL CARCINOMA ANTIGEN; CONFORMATIONAL-CHANGE; BIOLOGICAL-ACTIVITY; CRYSTAL-STRUCTURE; INCLUSION-BODIES; PURIFICATION; EXPRESSION; ENVIRONMENT;
D O I
10.1016/B978-0-12-385950-1.00002-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Serpins represent a diverse family of proteins that are found in a wide range of organisms and cellular locations. In order to study them, most need to be produced recombinantly, as isolation from their source is not always possible. Due to their relatively uncomplicated structure (single domain, few posttranslational modifications), the serpins are usually amenable to expression in Escherichia coli, which offers a fast and cost-effective solution for the generation of large amounts of protein. This chapter outlines the general procedures used in the expression and subsequent purification of serpins in E. coli, with a particular focus on the methods used for antitrypsin, the archetypal member of the family.
引用
收藏
页码:13 / 28
页数:16
相关论文
共 32 条
[1]   19F NMR studies of plasminogen activator inhibitor-1 [J].
Abbott, GL ;
Blouse, GE ;
Perron, MJ ;
Shore, JD ;
Luck, LA ;
Szabo, AG .
BIOCHEMISTRY, 2004, 43 (06) :1507-1519
[2]   Expression and purification of recombinant human α1-proteinase inhibitor and its single amino acid substituted variants in Escherichia coli for enhanced stability and biological activity [J].
Agarwal, Saurabh ;
Jha, Shweta ;
Sanyal, Indraneel ;
Amla, D. V. .
JOURNAL OF BIOTECHNOLOGY, 2010, 147 (01) :64-72
[3]   Recombinant protein expression in Escherichia coli [J].
Baneyx, F .
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (05) :411-421
[4]   Immunoractivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2: Implications for tumor marker detection [J].
Barnes, RC ;
Coulter, J ;
Worrall, DH .
GYNECOLOGIC ONCOLOGY, 2000, 78 (01) :62-66
[5]   A murine ortholog of the human serpin SCCA2 maps to chromosome 1 and inhibits chymotrypsin-like serine proteinases [J].
Bartuski, AJ ;
Kamachi, Y ;
Schick, C ;
Massa, H ;
Trask, BJ ;
Silverman, GA .
GENOMICS, 1998, 54 (02) :297-306
[6]  
BECERRA SP, 1993, J BIOL CHEM, V268, P23148
[7]   Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro [J].
Belorgey, D ;
Crowther, DC ;
Mahadeva, R ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) :17367-17373
[8]   Production of recombinant serpins in Escherichia coli [J].
Bird, PI ;
Pak, SC ;
Worrall, DM ;
Bottomley, SP .
METHODS, 2004, 32 (02) :169-176
[9]   Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen [J].
Blacque, OE ;
Worrall, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10783-10788
[10]   A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition [J].
Blouse, GE ;
Perron, MJ ;
Thompson, JH ;
Day, DE ;
Link, CA ;
Shore, JD .
BIOCHEMISTRY, 2002, 41 (40) :11997-12009